Neogenomics Inc (NEO)
$17.38 -3.07% Close Oct 30, 2026 Live
Neogenomics stock today
Neogenomics closed at $17.38 on October 30, 2026, down 3.07% on the day. Over the past year it returned +79.4% with dividends reinvested, against +12.4% for the S&P 500. Its market value is $2.23 billion.
$10.00$15.00$20.00
NovJan 2026MarMayJulSep
| Period | NEO | S&P 500 (SPY) |
|---|---|---|
| 1 month | -5.3% | -0.9% |
| 3 months | +9.4% | +2.1% |
| Year to date | +47.8% | +11.7% |
| 1 year | +79.4% | +12.4% |
| 3 years | +27.7% | +88.5% |
| 5 years | -62.2% | +76.0% |
Key statistics
- Market value
- $2.23B
- Forward P/E
- 58.8
- Price / sales
- 2.8
- 52-week range
- $7.19 to $19.91
About Neogenomics
Laboratory services company providing cancer genetic testing and diagnostics.
Sector: Health Care
More on Neogenomics
- Financials: revenue, earnings and segmentsRevenue +10% in the year to Dec 2025
- Returns: what $1,000 became$1,000 ten years ago is $2,159 today
No forecast, no recommendation. This page describes Neogenomics Inc from published data; it is not advice to buy, sell or hold any security.
Figures as of the close on Oct 30, 2026 unless a row says otherwise. Prices are split adjusted; returns include dividends reinvested. Data may be delayed. See the disclaimer and how TrendArc works.